Totient - Part of Absci Alternatives & Competitors
12 companies similar to Totient - Part of Absci — Artificial Intelligence for Drug Discovery
Vala Sciences
Vala enables precision drug discovery with fully automated analysis of hiPSC single-cell k...
San Diego, United States
OMass Therapeutics
OMass Therapeutics uses high-resolution mass spectrometry to discover drugs, targeting com...
Oxford, United Kingdom
MarineXcell Ltd.
Meeting Global Seafood Demand Sustainably: Your Source for High-Quality Shrimp, Lobster, a...
InterAx Biotech
Advanced integration of biological systems, math models and artificial intelligence
Switzerland
Track all Totient - Part of Absci competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Opentrons Labworks Inc.
We make open-source liquid handling robots for scientists.
United States
Cellecta, Inc.
Gene Functional Analysis. Simplified.
Mountain View, United Sta...
BI Biotech India Pvt. Ltd.
Your Trusted Partner for More Than Three Decades for your Research with Innovative Quality...
New Delhi, India
Dynamic42 GmbH
Develop human organ models with true physiological complexity
Jena, Germany
MEDGENOME
Leader in Genetic Testing Services, Genomics Research and Drug Discovery Solutions
Foster City, India
New England Biolabs
be INSPIRED, drive DISCOVERY, stay GENUINE
Ipswich, United States
APTBIO
Cutting-Edge Omics for Your Research.
Hong Kong S.a.r.
Ciloa SAS
Inspired by Exosomes
Montpellier, France
About Totient - Part of Absci
Artificial Intelligence for Drug Discovery
Generative AI for Biologics, Iterative AI-Wet Lab Model Development, Novel Antibody Target Discovery, Pipeline Development for Therapeutics
Pharmaceutical Companies, Biotechnology Firms, Academic Researchers
AI-driven Biotechnology, Drug Discovery, Tertiary Lymphoid Structures, Tissue-specific Antigens, High-affinity Antibody Therapeutics, Immune Response Analysis, Oncology Targets, Immunoinformatics, Bioinformatics, Antibody Reconstruction, Autoimmunity, Cancer Therapeutics, Infection Therapeutics, Antigen Discovery
B2B, Platform, API
Licensing, Service Fee, Performance Based
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Totient - Part of Absci and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Totient - Part of Absci on 2 Apr 2026. The 12 companies listed here were last checked between 3 Mar 2026 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.